Altre lingue OraSure Technologies, Inc.

Azioni

OSUR

US68554V1089

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
5,32 ^USD	+1,14%		+0,76%	-35,12%

27/02	Transcript : OraSure Technologies, Inc., 2023 Earnings Call, Feb 27, 2024
27/02	OraSure Technologies, Inc. Fornisce una guida alle entrate per il primo trimestre 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th	22/04
OraSure Technologies : Regulation FD Disclosure - Form 8-K	12/04
NOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the Board	22/03
OraSure: Q4 Earnings Snapshot	27/02
Earnings Flash (OSUR) ORASURE TECHNOLOGIES Posts Q4 Revenue $75.9M, vs. Street Est of $74.3M	27/02
Earnings Flash (OSUR) ORASURE TECHNOLOGIES Reports Q4 EPS $0.22, vs. Street Est of $0.11	27/02
OraSure Technologies, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023	27/02
OraSure Technologies, Inc. Provides Revenue Guidance for the First Quarter 2024	27/02
OraSure Reports Q4 ‘23 Revenue of $75.9 Million	27/02
OraSure Reports Q4 ‘23 Revenue of $75.9 Million	27/02
OraSure Technologies, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	27/02
OraSure Technologies, Inc. Seeks M&A	27/02
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th	13/02
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th	13/02
OraSure Technologies Leads Series B Funding, Strikes Distribution Rights With Sapphiros	04/01
Orasure Technologies, Inc. Secures Strategic Distribution Rights with Sapphiros	04/01
OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company	04/01
OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company	04/01
Sapphiros AI Bio LLC announced that it has received $30 million in funding from OraSure Technologies, Inc.	04/01
OraSure to Participate in Upcoming Investor Conferences	13/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue OraSure Technologies, Inc.

Azioni

OSUR

US68554V1089

Altre lingue

Filtri